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Abstract
Natural killer (NK) cells and their crosstalk with other immune cells are important for innate immunity against tumor. To
explore the role of the interaction between NK cells and macrophages in the regulation of anti-tumor activities of NK cells,
we here demonstrate that poly I:C-treated macrophages increased NK cell-mediated cytotoxicity against target tumor cells
in NKG2D-dependent manner. In addition, IL-15, IL-18, and IFN-b secreted by poly I:C-treated macrophages are also involved
in NKG2D expression and NK cell activation. Interestingly, the increase in expression of NKG2D ligands on macrophages
induced a highly NK cell-mediated cytotoxicity against tumor cells, but not against macrophages themselves. Notably, a high
expression level of Qa-1, a NKG2A ligand, on macrophages may contribute to such protection of macrophages from NK cell-
mediated killing. Furthermore, Qa-1 or NKG2A knockdown and Qa-1 antibody blockade caused the macrophages to be
sensitive to NK cytolysis. These results suggested that macrophages may activate NK cells to attack tumor by NKG2D
recognition whereas macrophages protect themselves from NK lysis via preferential expression of Qa-1.
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Introduction
Natural killer (NK) cells are an integral component of the innate
immune system and are characterized by their strong cytolytic
activity against tumors and virus-infected cells. NK cells also
regulate innate and adaptive immune responses through secretion
of immunoregulatory cytokines and cell-to-cell contact [1,2,3,4].
NK cells identify susceptible targets via a set of activating or
inhibitory receptors that recognize self-protein ligands that are
typically up-regulated in transformed or infected cells [1,2,5,6].
The activating receptor NKG2D is the best-characterized receptor
expressed by all NK cells and some subsets of NKT cells or T cells.
NKG2D could contribute to activation of NK cells via NKG2D-
NKG2D ligand interaction. The ligands for NKG2D in mice,
including retinoic acid early inducible-1 (RAE-1) proteins (RAE-
1a, b, c, d, and e), minor histocompatibility antigen (Ag) H60 and
murine UL16-binding protein-like transcript-1 (MULT-1) glyco-
protein, are expressed poorly by most normal cells but up-
regulated in tumor cells, infected cells or by cells under stress
[7,8,9]. CD94/NKG2A is one of the major inhibitory receptors in
mice, and it recognizes the non-classical major histocompatibility
complex (MHC) molecules Qa-1 that is expressed by most cell
types. It has been suggested that the Qa-1-CD94?NKG2A
interaction is critical for preventing NK cell-mediated killing of
mature dendritic cells (DCs) [10,11]. Therefore, the actions of NK
cells are thought to be mediated by the complex interactions
between inhibitory and activating signals sent by cell surface
receptors following ligation. Moreover, cytokines, such as in-
terleukin (IL)-2, IL-15, IL-12, IL-18 and IL-21, usually produced
by other immune cells, and particularly activated antigen-
presenting cells (APCs), also play important roles in the regulation
of NK cell activity [12,13].
The crosstalk between NK cells and other cellular lineages has
implications in the development of both innate and adaptive
immune responses. A great deal of interest and information has
emerged with respect to the DC and NK cell crosstalk in contrast
to the interactions between NK cells and other innate immune
system cells. DCs can activate resting NK cells under conditions
involving direct cell-to-cell contact, following stimulation with
various pathogens or by Toll-like receptor (TLR) ligands including
bacterial lipopolysaccharide (LPS) (an agonist of TLR4) and
polyriboinosinic-polyribocytidilic acid (poly I:C) (an agonist of
TLR3), leading to the development of dendritic-cell-activated
killers (DAKs) [14,15,16]. Macrophages are also important
effector cells of innate immune responses and can be found
distributed throughout the body poised to initiate innate and
acquired immune responses. They exert their function by directly
sensing a wide variety of pathogen-associated molecules via
pattern recognition receptors [17,18]. Recently, it has been shown
that there is also crosstalk between macrophages and NK cells,
which exerts important role in antitumor and antiinfection
responses [19,20,21,22]. For example, human macrophages
treated with LPS induced NK cell cytotoxicity and triggered NK
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human NKG2D ligands on LPS-activated macrophages mediated
the interaction between NK cells and macrophages [19].
However, it is still unclear how the interaction between NK and
macrophage affects NK-mediated cytotoxicity against tumor cells.
In this study, we observed that poly I:C-treated macrophages
increased NK cell-mediated cytotoxicity against tumor cells.
Interestingly, macrophages themselves were not killed by these
activated NK cells. Further results indicated that the preferential
expression of Qa-1, the NKG2A ligand, protected macrophages
from cytolysis of NK cells.
Materials and Methods
Mice and Cell Lines
BALB/c and C57BL/6 mice (6 to 8 weeks-old) were purchased
from the Experimental Animal Center of Beijing University
(Beijing, China) and maintained under specific pathogen-free
conditions. All animal experiments and protocols were approved
by the Committee on the Ethics of Animal Experiments of the
Shandong University. The murine macrophage-like cell line
RAW264.7, the murine lymphoma cell line YAC-1, the murine
colon adenocarcinoma cell line MCA-38, the murine hepatocel-
lular carcinoma cell line Hepa1-6, and the murine ascitic
hepatoma cell line and H22 were grown at 37uC with 5% CO2
in RPMI 1640 medium (Invitrogen, Carlsbad, CA) supplemented
with 100 U/ml penicillin, 100 mg/ml streptomycin and 10% fetal
bovine serum (FBS).
Activation of Macrophages in vitro
Resident peritoneal macrophages from wild-type mice were
harvested by peritoneal lavage with 5 ml of cold phosphate-
buffered saline (PBS). Cells were centrifuged (3506g, 5 min) at
room temperature and allowed to adhere to 6-well plates for 2 h
(nonadherent cells were removed by washing with PBS). The
adherent cells (primary macrophages) or RAW264.7 cells were
incubated with medium or various concentrations of poly I:C
(Sigma, St. Louis, MO). To investigate the contact dependence of
the interaction, macrophages and NK cells were separated by
a membrane (0.4-mm pore size) in Transwell plates (Costar;
Corning) in some experiments.
Real Time (RT)-PCR Analysis
Total RNA was isolated from cells using TRIzol as described by
the manufacturer (Invitrogen). cDNA was generated with Oligo
dT primer using M-MLV reverse transcriptase (Promega,
Madison, WI) according to the manufacturer’s protocol. PCR
primers for detecting the indicated mRNA (Sangon Ltd.,
Shanghai, China) are described in Table 1. Triplicate 20 ml
PCR reactions were carried out using SYBR Green Supermix
(BioRad) incubated for 10 min at 95uC followed by 45 cycles
consisting of 95uC for 15 s, 60uC for 15 s and 72uC for 15 s. The
levels of mRNA were normalized to that of b-actin.
NK Cell Isolation
Splenocytes were incubated with anti-CD49b (DX-5, isotype:
rat IgM; clone: DX-5) microBeads (Miltenyi Biotec, Auburn, CA)
and DX-5
+ cells (NK cells) were isolated using MACS Separation
Columns (Milteny Biotec, Auburn, CA) according to the
manufacturer’s instructions. CD49b
+ NK cells were identified by
flow cytometry using a FITC-conjugated anti-CD49b antibody
(Ab) (isotype: rat IgG; clone: HMa2; eBioscience) and the purity
was confirmed to be $85%. For in vitro analyses, DX-5-sorted cells
were cultured in RPMI 1640 supplemented with 100 U/ml
human IL-2 (Peprotech, London, UK) to maintain the activity of
NK cells.
Cytotoxicity Assays
NK cell-mediated cytotoxicity was determined by
51Cr release
assay (11). Prior to incubation with
51Cr -labeled target cells, NK
cells were pre-incubated with poly I:C-untreated or -treated
macrophages. Target cells were seeded into 96 well round-bottom
plates at 2610
4 cells per well. Effector cells were added to target
cells at effector/target (E/T) ratios of 50:1, 25:1 and 5:1
separately. For NKG2D or Qa-1 blocking assays, NK cells or
macrophages respectively were treated with 10 mg/ml purified
anti-mouse NKG2D- or Qa-1 neutralizing mAb (R&D Systems,
Minneapolis, MN) for 4 h before being used. For IL-15 or IFN-
b blocking assays, NK cells were cultured with poly I:C-untreated
or -treated macrophages in the presence of 10 mg/ml anti-IL-15,
anti-IFN-b, or isotype control mAbs, and then NK cells were
added to target cells. The cell mixtures were then incubated for
Table 1. Sequences of primer used for real-time PCR assay.
Target
sequence Sequence (59-39) size (bp)
b-actin R: AGAGGGAAATCGTGCGTGAC
F: CAATAGTGATGACCTGGCCGT
139
RAE-1 R: ATCAACTTCCCCGCTTCCA
F: AGATATGAAGATGAGTCCCACAGAGATA
79
H60 R: GAGCCACCAGCAAGAGCAA
F: CCAGTATGGTCCCCAGATAGCT
75
MULT-1 R: TTCACATAGTGCAGGAGACTAACACA
F: ACTGGCCACACACCTCAGC
69
Qa-1a R: GCGGTATTTCCACACTGCCA
F: TCTGTGAGGCAAAGTCAGTC
80
Qa-1b R: CCTGGACCGCGAATGACATA
F: CACCACAGCTCCAAGGATGAT
514
NKG2D R: ACGTTTCAGCCAGTATTGTGC
F: GGAAGCTTGGCTCTGGTTC
132
TRAIL R: CCCTGCTTGCAGGTTAAGAG
F: G GCCTAAGGTCTTTCCATCC
240
FasL R: AAGAAGGACCACAACACAAATCTG
F: CCCTGTTAAATGGGCCACACT
233
Perforin R: GAGAAGACCTATCAGGACCA
F: AGCCTGTGGTAAGCATG
166
TLR3 R: TCTGGAAACGCGCAAACC
F: GCCGTTGGACTCTAAATTCAAGAT
85
TLR4 R: AGAAATTCCTGCAGTGGGTCA
F: TCTCTACAGGTGTTGCACATGTCA
84
IL-18 R: GCCATGTCAGAAGACTCTTGCGTC
F: GTACAGTGAAGTCGGCCAAAGTTGTC
122
IL-15 R: TTAACTGAGGCTGGCATTCATGTCTTC
F: CAGTTCATTGCAGTAACTTTGCAACTG
194
IL-12p35 R:CATCGATGAGCTGATGCAGT
F: CAGATAGCCCATCACCCTGT
163
IL-12p40 R:TGGAAGCACGGCAGCAGAATAAAT
F:TGCGCTGGATTCGAACAAAGAACT
202
IFN-b R:CCATCATGAACAACAGGTGGAT
F:GAGAGGGCTGTGGTGGAGAA
67
IFN-c R: TGCATCTTGGCTTTGCAGCTCTTCCTCATGGC
F: TGGACCTGTGGGTTGTTGACCTCAAACTTGGC
194
IFN-a R: TCTGTGCTTTCCTCGTGATG
F: TTGAGCCTTCTGGATCTGCT
215
doi:10.1371/journal.pone.0036928.t001
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51Cr release
using a gamma radiation counter. Percentage of specific lysis was
determined by the formula: (sample release - spontaneous release)/
(maximum release-spontaneous release) 6100%.
Flow Cytometric Analysis
For cell surface staining, cells were harvested, blocked with anti-
FccR mAb, and stained with the labeled mAbs at 4uC for 45 min.
For intracellular cytokine staining, cells were cultured in RPMI
1640 containing 10% FCS, and treated with monensin (Sigma) for
4 h to inhibit extracellular secretion of cytokines. IFN-c was
determined by intracellular flow cytometry. The antibodies used
were as followed: carboxyfluorescein-conjugated RAE-1, FITC-
conjugated MULT-1, PE-conjugated H60 (R&D Systems), anti-
mouse NKG2D mAb (R&D System), PE-conjugated Ab to CD68,
CD69 or IFN-c (R&D System), FITC-conjugated affinity-purified
goat anti-rat IgG (ZSGB-BIO, China) or isotype controls
(eBioscience, San Diego, CA, USA). All mAbs were used at a final
concentration of 10 mg/mL. All stained cells were analyzed using
a flow cytometer (FACScalibur, USA), and the data were
processed with WinMDI 2.9 software (Scripps Research Institute).
ELISA for Cytokine Detection
The level of IFN-c in cell culture supernatants was detected by
commercial enzyme-linked immunosorbent assay (ELISA) kits
(R&D Systems), following the manufacturers’ instructions. The
levels of IL-12, IL-15 and IFN-b were measured using ELISA kits
(Adlitteram Diagnostic, USA).
RNA Interference
Transfections of siRNAs targeting Qa-1 or TLR3 were carried
out using lipofectamine 2000 (Invitrogen, Carlsbad, CA) at a final
small interfering (si) RNA concentration of 100 nM according to
the manufacturer’s instructions. The sense siRNA strands used in
this study were as follows: Qa-1, GAAGAGGAGGAGACA-
CAUA and TLR3, GAGCATCAATCTAGGACTGAA. All
siRNAs were purchased from Ribobio (Guangzhou, China).
Statistical Analysis
In each experiment, the results were expressed as the mean 6
SD. Student’s t test was used to compare the differences between
two different groups, and P,0.05 was considered statistically
significant.
Figure 1. Murine macrophages increase NK cell cytotoxicity to susceptible target cells. Freshly purified splenic NK cells were first co-
cultured with untreated or poly I:C-pretreated macrophages for 24 h at an NK/macrophage ratio of 5:1, and then separated by vibrating gently to be
used as effector cells against susceptible target cells. NK cell-mediated lysis against YAC-1 cells, Hepa1-6 cells, MCA38 cells, H22 cells (A), RAW264.7
cells (B) or peritoneal Mw (C) was assessed by the
51Cr release assay at various E:T rations. Data are expressed as the mean 6 SD from at least three
separate experiments. *p,0.05, **p,0.01 versus untreated cells using the paired Student’s test.
doi:10.1371/journal.pone.0036928.g001
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Poly I:C-treated Macrophages Increase NK Cell-mediated
Cytotoxicity to Target Tumor Cells, but not to
Macrophages
To investigate whether poly I:C-treated macrophages affect NK
cell-mediated cytotoxicity, we used
51Cr -labeled tumors as targets.
The splenic CD49
+ NK cells were isolated and purified from
BALB/c or C57BL/6 mice. The purity (85%–92%) was
confirmed by flow cytometry analysis (data not shown). These
splenic NK cells were co-cultured with poly I:C-treated
RAW264.7 cells for 24 h at NK/macrophage ratios of 5:1, and
then separated to be used as effector cells against tumor cells. The
purity of splenic NK cells isolated from macrophages was greater
than 90% (Fig. S1). NK cytotoxicity against YAC-1 cells, Hepa1-6
cells, MCA38 cells or H22 cells was dramatically increased when
NK cells were pre-incubated with poly I:C-treated macrophages
(Fig. 1A). Among these target cells, YAC-1 was most sensitive to
NK cells isolated from poly I:C-treated macrophages (p,0.05 at
E:T ration of 5:1 and 25:1, and p,0.01 at E:T ration of 50:1,
respectively, compared with that of NK cells isolated from
untreated macrophages). And we also found that compared with
untreated NK cells, exposure to untreated macrophages did not
result in an increase of NK cells cytotoxicity against both type of
target cells (Fig. 1A). These data suggested that poly I:C-treated
macrophages significantly enhanced NK cell-mediated cytotoxic-
ity to tumor cells.
Interestingly, no statistically difference was found in NK cells
cytotoxicity to resting RAW264.7 cell line, when comparing poly
I:C-treated macrophages incubated NK cells with untreated
macrophages incubated NK cells or untreated NK cells (data
not shown). We further tested whether poly I:C-treated macro-
phages enhance the cytolytic capacity of NK cells against poly I:C-
treated macrophages themselves. We found that NK cells isolated
from poly I:C-treated RAW264.7 cells exerted slightly higher
cytotoxicity against poly I:C-treated RAW264.7 cells than that
against untreated RAW264.7 cells only at the E:T ratio of 50:1,
with the cytotoxicity increased from 28.861.93% to 39.761.1%
(p,0.05) (Fig. 1B). Neither untreated nor poly I:C-treated
peritoneal macrophages were lysed by activated autologous NK
cells (Fig. 1C).
Figure 2. Poly I:C-treated macrophages enhanced NKG2D expression and NK cell function. Freshly isolated splenic NK cells were co-
cultured with RAW264.7 cells that were treated with 0 or 100 mg/ml of poly I:C for 24 h. NK cells were then isolated and NKG2D expression was
determined by RT-PCR and flow cytometry (A). Data are expressed as the fold change in mRNA expression normalized to untreated cells or as the
percentage of positively-stained cells. * p,0.05 versus untreated cells using the paired Student’s test. The isolated NK cells from co-culture with
macrophages were co-incubated with saturating amounts of anti-NKG2D mAb or isotype control, washed and used as effector cells against YAC-1
targets (B). The expression of CD69 (C), cytotoxic effector molecules FasL, TRAIL, and perforin (D), and seceretion of IFN-c (E) were determined by flow
cytometry, RT-PCR, and ELISA separately. Data are expressed as the mean 6 SD from at least three separate experiments. *p,0.05, **p,0.01
compared with poly I:C-untreated RAW264.7 group;
# p,0.05,
## p,0.01 compared with isotype control group.
doi:10.1371/journal.pone.0036928.g002
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Since NKG2D is an activating receptor for NK cell activation,
we determined NKG2D expression on NK cells following
exposure to poly I:C-treated macrophages. The splenic NK cells
were co-cultured with untreated or poly I:C-treated RAW264.7
cells for 24 h, and NKG2D expression was then analyzed by RT-
PCR and flow cytometry. As shown in Fig. 2A, NKG2D
expression was markedly increased on splenic NK cells following
exposure to poly I:C-treated RAW264.7 cells at both the mRNA
and protein levels. We also examined expression of other
activating receptors, such as DNAM-1 and NKp46, on NK cells,
but found no significant difference on the surface of NK cells co-
cultured with untreated or poly I:C-treated macrophages (data not
shown). To determine the relative contributions of NKG2D
expression on NK cell-mediated lysis, splenic NK cells were first
co-cultured with poly I:C-treated RAW264.7 cells for 12 h at an
NK/macrophage ratio of 5:1, and were then co-incubated with
saturating amounts of anti-NKG2D mAb or isotype control. NK
cells were then washed and used as effector cells against YAC-1
targets. As demonstrated in Fig. 2B, anti-NKG2D mAbs
significantly attenuated the NK cell-mediated lysis of YAC-1 cells
at every E:T ratio examined (p,0.05, compared with isotype
control or without antibody incubation), suggesting that the
increased NK cell-mediated YAC-1 lysis was dependent on the
activating receptor NKG2D.
The activation status of NK cells following co-culture with poly
I:C-treated macrophages was further examined by measuring
CD69 expression on NK cells which was significantly up-regulated
with the percentage of CD69
+ NK cells increased from 25.71% to
62.52% (Fig. 2C). In addition, the cytotoxic-related molecules,
TNF-related apoptosis-inducing ligand (TRAIL), perforin, and
FasL were significantly up-regulated following incubation with
poly I:C-treated macrophages (Fig. 2D). And the level of IFN-c in
NK cell supernatants increased significantly after co-cultured with
poly I:C-treated macrophages for 12 h (Fig. 2E). To investigate
whether NKG2D contributed to the activation status of NK cells,
we added saturating amounts of anti-NKG2D mAb or isotype
control when incubation of NK cells and poly I:C-treated
macrophages. We found that blockade of NKG2D alleviated the
expression of CD69 (Fig. 2C), perforin, FasL and TRAIL on NK
cells (Fig. 2D), and reduced the level of IFN-c in the supernatants
(Fig. 2E). These experiments demonstrated that poly I:C-treated
macrophages activated NK cells by up-regulating NK cell lysis-
associated molecules and NKG2D surface expression which
correlated with significantly enhanced target cell lysis.
Figure 3. Up-regulation of NKG2D ligands on poly I:C-treated murine macrophages. Murine macrophage RAW264.7 cells were cultured for
24 h with 0, 10, 20 or 100 mg/ml poly I:C and analyzed by RT-PCR or FACS. The data are expressed as fold induction of RAE-1, H60 or MULT-1 mRNA
(A) or the percentage of positive RAE-1 staining using monoclonal pan-RAE-1 antibodies (B). Resident peritoneal macrophages from BALB/c or C57BL/
6 mice were treated with either 0 or 100 mg/ml poly I:C for 24 h and NKG2D ligand transcripts and surface expression were analyzed by real-time PCR
(C) or FACS (B). Data shown are expressed as the mean 6 SD from at least three separate experiments. *p,0.05, **p,0.01 compared with untreated
cells.
doi:10.1371/journal.pone.0036928.g003
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Because the interactions between NKG2D and its ligands could
mediate NK cells activation, we attempted to determine the
changes in the levels of the NKG2D ligands RAE-1, H60 and
MULT-1 on RAW264.7 cells following stimulation with poly I:C
for 24 h at 0, 10, 20, or 100 mg/ml by RT-PCR. The results
showed that the transcripts for these three NKG2D ligands were
significantly elevated following poly I:C treatment in a dose-
dependent manner (p,0.05 with 10 or 20 mg/ml poly I:C
incubation and p,0.01 with 100 mg/ml poly I:C incubation
when compared with untreated cells) (Fig. 3A) and a dose-
dependent increase in RAE-1 expression was also detected by flow
cytometry (Fig. 3B). In addition, resident peritoneal macrophages
harvested from BALB/c and C57BL/6 mice were treated with
either 0 or 100 mg/ml poly I:C for 24 h and examined by RT-
PCR for RAE-1, H60 and MULT-1 expression. Compared with
untreated cells, incubation with poly I:C significantly increased
transcript levels for each NKG2D ligand examined (p,0.01)
(Fig. 3C). Then ligand surface expression paralleled the transcript
levels was detected. Flow cytometry analysis showed a dose-
dependent increase for RAE-1 expression from both BALB/c and
C57BL/6 mice over a 24 h period (Fig. 3B). The expression of
H60 and MULT-1 on primary peritoneal macrophages also
augmented (Fig. 3B). These results demonstrated that poly I:C
could up-regulate NKG2D ligand expression on murine macro-
phages in a dose-dependent manner.
Poly I:C-induced Up-regulation of NKG2D Ligands is
Dependent on TLR3
Poly I:C can bind to and up-regulate TLR3 expression on some
tumor cells and enhances cycloheximide-induced apoptosis via
a TLR3 pathway [23]. We also measured whether the expression
of NKG2D ligands on murine macrophages would be dependent
on TLR activation. Poly I:C treatment augmented the expression
of TLR3 mRNA of RAW264.7 (Fig. 4A) and peritoneal
macrophage (data not shown), but not TLR4. When TLR3
expression on RAW264.7 cells was silenced by TLR3 specific
siRNA (Fig. 4B), poly I:C-mediated up-regulation of the three
NKG2D ligands was abrogated significantly (Fig. 4C), suggesting
that the up-regulation of NKG2D ligands on macrophages by poly
I:C treatment was TLR3-dependent.
Qa-1 Contributes to the Protection of Macrophages from
NK Cell-mediated Cytolysis
It has been documented that NK cell activation is tightly
regulated by signals from an array of cell-surface inhibitory and
activating receptors that interact with target cell ligands e.g., signals
transmitted by inhibitory receptors for MHC class I molecules
inhibited NK cell-mediated cytolysis [1,2]. Recent studies have
demonstrated that Qa-1b is critically involved in regulating IFN-c
Figure 4. TLR3 is necessary for poly I:C-mediated up-regulation of NKG2D ligands by macrophages. Expression of TLR3 and TLR4 by
RAW264.7 cells stimulated with 100 mg/ml poly I:C for 24 h was analyzed by RT-PCR (A). TLR3 mRNA levels of RAW264.7 cells were measured
following incubation in media only or following treatment with si-TLR3 or siRNA control (si-control) for 24 h (B). The data are expressed as the folds 6
SD from at least three separate experiments. *p,0.05, **p,0.01 compared with the untreated group. RAW264.7 cells first transfected with si-TLR3 or
si-control were stimulated with 0 or 100 mg/ml poly I:C for 24 h and the transcripts of the NKG2D ligands RAE-1, H60, and MULT-1 were detected by
RT-PCR (C). The data are expressed as the mean induction folds 6 SD over untreated cells from at least three separate experiments. *p,0.05,
compared with si-control group.
doi:10.1371/journal.pone.0036928.g004
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NKG2A inhibitory receptors that may protect DC from NK cell-
mediated cytolysis even in the absence of classical MHC class I
molecules [11,24]. To address whether Qa-1 was also critical in
protecting murine macrophages from NK cell-mediated killing, we
first compared the expression level of Qa-1 mRNA in poly I:C-
treated or untreated macrophages (RAW264.7 cells and peritoneal
macrophages freshly isolated from BALB/c mice) and found no
significant changes in the Qa-1a and Qa-1b transcript levels
following poly I:C stimulation, but the levels of Qa-1a in poly I:C-
treated or untreated primary macrophages are much higher than
that in YAC-1 cells by 16.761.98 folds and 16.960.97 folds
separately, and the levels of Qa-1b in primary macrophages are
higher by about 10 folds (Fig. 5A). Even for RAW264.7 cells, Qa-
1a expression is higher than that in YAC-1 cells by 1.7860.31 and
2.1760.42 folds, and Qa-1b expression is higher by 9.7560.43
and 11.9561.45 folds, respectively (Fig. 5A). Similar results were
obtained from the total Qa-1b expression in the three cell types by
flow cytometry (Fig. 5B). We also compared the transcription
levels of NKG2D ligands in the three cell types and found that the
expression of three NKG2D ligands, RAE-1, H60 and MULT-1,
was lower in murine primary macrophages than in YAC-1 cells.
After treatment with poly I:C, the levels were equivalent with that
in YAC-1 cells. As for RAW264.7 cells and YAC-1 cells, the
expression of NKG2D ligands was nearly at the same level, except
that RAE-1 expression was increased significantly after poly I:C
stimulation (Fig. 5C). These results suggested that the expression of
inhibitory ligands on macrophages was predominant than that of
activating ligands if compared with YAC-1 cells.
To further investigate whether Qa-1 expression contributed to
the protection of murine macrophages from NK cell-mediated
cytotoxicity, we first incubated RAW264.7 cells with saturating
amounts of anti-Qa-1b mAb to block the interaction of Qa-1 with
its receptor CD94/NKG2A. We found that blockade of Qa-1
significantly enhanced the cytotoxicity of NK cells stimulated with
poly I:C-treated RAW264.7 cells against poly I:C-treated
RAW264.7 cell line (Fig. 5D). We further used siRNA to knock
down the Qa-1 expression of RAW264.7 cells. As shown in Fig.
S2A, the Qa-1 mRNA levels were significantly reduced after Qa-1
siRNA treatment, and NK cell-mediated cytolysis of poly I:C-
Figure 5. Qa-1 contributes to the protection of macrophages from NK cell-mediated lysis. Changes in mRNA and protein levels of the
NKG2A ligands Qa-1a and Qa-1b (A,B), and the NKG2D ligands RAE-1, H60, and MULT-1 (C) in YAC-1 cells, macrophages (Mw) or RAW264.7 cells were
detected by RT-PCR or FACS. Data are expressed as relative expression from at least three separate experiments. *p,0.05, **p,0.01 versus YAC-1
mRNA levels using the paired Student’s test. RAW264.7 cells first stimulated with 100 mg/ml poly I:C for 24 h and then co-incubated with saturating
amounts of anti-Qa-1 mAb or isotype control or transfected with si-Qa-1 or si-control, were then used as target cells. The cytolytic activity of NK cells
stimulated with poly I:C-treated macrophages was assessed at various E:T rations (D). Data are expressed as the mean 6 SD from at least three
separate experiments. *p,0.05, **p,0.01 compared with the isotype control or si-control group.
doi:10.1371/journal.pone.0036928.g005
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increased at the highest E:T ratio (50:1) (p,0.05) (Fig. 5D).
In addition, we investigated the NKG2A molecule expression
on NK cells and found no significant difference on the surface of
NK cells when co-cultured with untreated or poly I:C-treated
macrophages (Fig. S2B). Next, splenic CD49
+ NK cells were
treated with NKG2A-siRNA or control-siRNA before incubation
with RAW264.7 cells. We found that silence of NKG2A on NK
cells enhanced the NK cell-mediated lysis of macrophages (Fig.
S2C and Fig. S2D). These results suggested that the interaction of
Qa-1 and NKG2A plays a critical role in protection of murine
macrophages from NK cell-mediated lysis even when NKG2D
ligands were up-regulated on macrophages. Although we can not
rule out the role of other inhibitory receptors, the data from Qa-1
knockdown and blockade of Qa-1 and NKG2A did supported the
idea that Qa-1 plays major roles in protection of macrophages
from NK lysis.
Poly I:C-stimulated Production of Cytokines by
Macrophages also Play a Critical Role in NK Cell
Activation
It has been documented that poly I:C stimulation induced the
production of several cytokines by macrophages or DCs e.g., IFN-
b, IL-12, and IL-15 [25,26,27]. We next investigated whether
cytokines produced by poly I:C-treated macrophages were in-
volved in NK cells activation. First, changes in the protein levels of
IL-12, IL-18, IL-15, IFN-b and IFN-c were detected by ELISA in
the supernatants of RAW264.7 cells and peritoneal macrophages.
The results showed that poly I:C stimulation did not affect IFN-c
Figure 6. Cytokines secreted by poly I:C-treated macrophages play critical roles in NK cell activation. The secretion levels of IL-12, IL-15,
IL-18, IFN-b, or IFN-c in the supernatants of RAW264.7 cells (A) or resident peritoneal macrophages from BALB/c mice (B) that were cultured with 0 or
100 mg/ml poly I:C for 24 h were analyzed by ELISA. The data are expressed as the mean 6 SD from at least three separate experiments. *p,0.05,
**p,0.01 compared with the untreated RAW264.7 group. NK cells were incubated with poly I:C-pretreated RAW264.7 cells in the presence of 10 mg/
ml anti-IL-15 mAb, anti-IFN-b mAb or isotype control separately for another 12 h, and the expression of NKG2D were determined by flow cytometry
(C). Levels of IFN-c in the supernatants were determined by ELISA (D). NK cell-mediated lysis of YAC-1 cells was assessed by first culturing NK cells
with poly I:C-treated RAW264.7 cells (Mw) in the presence or absence of anti-IL-15 mAb, anti-IFN-b mAb or isotype control, respectively, and then NK
cells were isolated and added to target cells (E). Data are expressed as the mean 6 SD from at least three separate experiments. *p,0.05 compared
with the isotype control group.
doi:10.1371/journal.pone.0036928.g006
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12 were markedly increased in RAW264.7 cells (Fig. 6A). High
level of IL-15 and IFN-b were also found in BALB/c peritoneal
macrophages after poly I:C stimulation (Fig. 6B). To investigate
whether these two cytokines contributed to the activation status of
NK cells, NK cells were cultured with poly I:C-untreated or -
treated macrophages in the presence of 10 mg/ml of anti-IL-15 or
anti-IFN-b blocking mAb, or isotype control mAbs. Blocking
either IL-15 or IFN-b decreased expression of NKG2D (Fig. 6C)
and CD69 (data not shown) on NK cells significantly. The
secretion of IFN-c by NK cells was also suppressed by blockade
with IL-15 mAb, although it was not impaired by IFN-
b neutralization (Fig. 6D). Moreover, with blockade of either of
the two cytokines, NK cell-mediated lysis against YAC-1 cells was
significantly attenuated (Fig. 6E). These data suggested that
cytokines produced by poly I:C-stimulated macrophages, also
play critical role in NK cell activation. We further use transwell
culture to prohibit cell-to-cell contact between NK cells and
macrophages. As shown in Fig. 7, poly I:C-stimulated primary
macrophages still promote the expression of CD69 and NKG2D,
as well as production of IFN-c by NK cells, although the up-
regulation effect is not as strong as that in direct contact coculture.
These finding indicated that both cell-to-cell contact and cytokines
secreted by poly I:C-stimulated macrophages play major roles in
NK cell activation.
Discussion
NK cells are bone marrow (BM)-derived lymphocytes involved
in immune recognition of infected cells and tumors. They are not
only important players of innate effector responses, but also
participate in the initiation and development of antigen-specific
responses. The presence of both activating and inhibitory
receptors on the surface of NK cells act collaboratively with
cytokines to regulate NK cell functions [1,2,3,4]. The immuno-
regulatory crosstalk between NK cells and APCs has been of great
interest, specifically crosstalk between DC and NK cells
[14,15,16,21]. However, less attention has been given to reciprocal
interaction between NK cells and other APC populations e.g.,
macrophages that are also important immune effector cells
providing immune surveillance against a variety of microbes and
tumors [17,22].
Poly I:C is a synthetic, double-stranded RNA TLR3 agonist and
a potent stimulator of type I IFN production [28,29]. In the
present study, poly I:C was used to stimulate murine macrophages
which resulted in NKG2D-dependent upregulation of NK cell-
mediated cytotoxicity to susceptible target, which suggests a role
for TLR3 signaling in the activation of NK cells upon the
interaction between NKG2D and its ligands. We demonstrated
a poly I:C-dependent upregulation of NKG2D ligands on
macrophages and the contribution of poly I:C-treated macro-
phages to NK cell lysis against tumor cells in both NKG2D- and
cytokine-dependent manner. In accordance with our report, IFN-
c production by NK cells was shown to be cell to cell contact
dependent through RAE-1-NKG2D interaction with macro-
phages in response to B. anthracis spores [22]. Moreover, other
TLR agonists (e.g. LPS), cytokines (e.g. IFN-a, IL-15) or parasite
infection, stimulated macrophages or DCs were also found to
activate NK cells by increasing expression of NKG2D ligands, and
thus augment NK cell-mediated cytotoxicity to tumor or infected
Figure 7. Both cell-to-cell contact and cytokines were involved in the crosstalk between NK cells and macrophages. Freshly isolated
murine NK cells were co-cultured with poly I:C-stimulated primary macrophages separated by a transwell for 24 h. Then NK cells were stained with
antibodies for cell-surface CD69 and NKG2D, and for intracellular IFN-c. The numbers of CD69- or NKG2D-positive as well as IFN-c-secreting NK cells
were determined by flow cytometry. Data are expressed as the percentage of positively-stained cells. The data are representatives from at least three
separate experiments.
doi:10.1371/journal.pone.0036928.g007
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may also contribute to lysis of NK cells during the interaction with
macrophages. NCR1 (murine NKp46) was reported to be
important for NK cell activation during the interaction with S.
pneumoniae-infected BMMQ [34]. In human, IFN-c production
of NK cell was shown require the interaction of DNAM-1 and 2B4
with their ligands on macrophage exposure to LPS or bacillus
Calmette–Gue ´rin [35]. And NK cell degranulation triggered by
interaction with human cytomegalovirus-infected macrophage was
inhibited by specific anti-NKp46, anti-DNAM-1, and anti-2B4
mAb [36].
Interestingly, poly I:C-treated macrophages increased NK cell-
mediated cytotoxicity against tumor cell, but the macrophages
themselves were not killed by NK cells although they exerts
increased level of NKG2D ligands expression. These results are in
agreement with the recent report that activated NK cells exhibited
cytolytic properties against tumor targets but not the infected host
macrophage [37]. After comparing the expression levels of ligands
for NKG2A and NKG2D between macrophages and YAC-1
targets, we found that a predominant inhibitory signal resulting
from NKG2A-ligation over a NKG2D stimulating signal might
contribute to the non-sensitive response of macrophages to NK
cytolysis. Therefore, we proposed that although poly I:C treatment
increased expression of NKG2D ligands on macrophages,
signaling via NKG2D receptor was incapable of overriding Qa-
1-derived inhibitory signals, and finally can not lead to cytolysis of
themselves by NK cells. As for YAC-1 target, the higher
expression level of activating ligands and lower expression level
of inhibitory ligands might results in predominant activating
signaling when contacted with NK cells. In line with the role of
inhibitory ligands, it was documented that the inhibitory ligand
HLA-E played an important role in the interaction between
polyI:C/IFN-c activated DC and NK cells [21]. The infected
proinflammatory (M1) macrophages with high expression of HLA,
were more resistant to lysis of NK cells than undifferentiated (M0)
and antinflammatory (M2) macrophages [35,36]. In our experi-
mental system, we hypothesized that these macrophages may be
polarized toward M1-like macrophages, as these cells could secrete
high level of IL-12 that was a phenotypic character of M1
macrophages. To our knowledge, this is the first report to declare
that the preferential expression of inhibitory ligand Qa-1 protected
macrophages from cytolysis of NK cells, although other researches
have also reported that Qa-1 plays critical role in protection of
mature dendritic cells, activated CD4
+ T cells, or iNKT cells from
NK cell-mediated killing [11,23,27,38,39].
Although NKG2D ligation results in NK cell activation and
provides CD8
+T cell costimulation, it has been reported that
sustained binding of NKG2D by its ligands might impair surface
expression of functional NKG2D by NK and T cells i.e.,
prolonged exposure to ligands may desensitize NKG2D on NK
cells and T cells, rendering these cells functionally anergic
[40,41,42]. Hamerman also reported that LPS or Listeria
monocytogenes-treated macrophages reduced NKG2D levels on
NK cells both in vitro and in vivo [30]. However, in the present
study, we did not find the down-regulation of the NKG2D
receptor on NK cells following coculture with poly I:C-treated
macrophages. In contrast, we observed that NKG2D expression
was markedly increased on splenic NK cells upon exposure to poly
I:C-treated macrophages both at the mRNA and protein levels. It
has been documented that some cytokines, such as IL-15, IL-12,
IL-2, and IFN-a, upregulated NKG2D expression on NK or
CD8
+ T cells [43,44,45,46]. More importantly, IL-15 and IL-2
treatment overcame ligand-induced NKG2D downregulation,
enabling NK cells to exhibit substantially enhanced cytotoxicity
against tumor cells [47]. We proposed that poly I:C-induced
production of cytokines such as IFN-b, IL-12, and IL-15 by poly
I:C-treated macrophages overcame the ligand-induced NKG2D
downregulation, since antibodies to IL-15 or IFN-b attenuated the
expression of NKG2D on NK cells (Fig. 6C). Wang recently also
reported that IFN-c up-regulated membrane IL-15 expression on
monocytes prevented NKG2D down-regulation following ligation
to NK cells [48]. Meanwhile, our results also strongly showed that
the secretion of IFN-b, IL-15, and IL-18 by macrophages
contributed to NK cell activation in collaborate with the
interaction of NKG2D and its ligands. And these results support
the view that the expression of activation markers and the
acquisition of cytotoxicity of NK cell against tumor cells required
IL-18 and IL-12 released from macrophages [22,35].
Based on our results, we propose that there is a cross-talk
between NK cells and macrophages, which may play major roles
in defense against tumors and infectious pathogens. As illustrated
in Figure 8, poly I:C stimulation induces up-regulation of NKG2D
ligands and secretion of IL-15, IL-12, or IFN-b by macrophages.
The interaction of NKG2D and NKG2D ligands as well as these
cytokines contribute to NK cell activation. Then the activated NK
cells recognize tumor cells by NKG2D, followed by increased
secretion of cytotoxic molecules and cytokine IFN-c, leading to
attacking tumors. On the other hand, NKG2A ligand Qa-1
Figure 8. Working model of innate recognition-mediated
interaction between NK cells and macrophages during anti-
tumor immune response. As a response to stimulation from TLR3
ligand poly I:C, macrophages up-express surface RAE-1 (NKG2D ligand)
and produce soluble IL-12, IL-15, and IFN-b. RAE-1 on surface of
macrophages and their cytokines will strongly activate NK cells to
produce IFN-c and up-expression of NKG2D. IFN-c produced by NK cells
will stimulate macrophages in feedback. NK cells after activation will
directly attack tumor cells by recognizing tumor’s RAE-1 and indirectly
arrest tumor growth by secreting IFN-c. At the same time, poly I:C-
induced up-regulation of NKG2A ligand Qa-1 protects macrophages
themselves from cytolysis by NK cells in order to keep the positive
feedback loop in the anti-tumor immune response.
doi:10.1371/journal.pone.0036928.g008
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concluded that the interactions between NK cells and macro-
phages contributed to anti-tumor immune responses and the
innate recognition-mediated crosstalk plays a critical role in this
process.
Supporting Information
Figure S1 The purity of splenic NK cells isolated from
mixed culture cells. NK cells were first co-cultured with
macrophages, and then were separated from macrophages. The
purity was determined by flow cytometry. The data are expressed
at least three separate experiments.
(TIF)
Figure S2 NKG2A contributes to the protection of
macrophages from NK cell-mediated lysis. Following
transfection with either pan-Qa-1 siRNA (si-Qa-1) or si-control
complexed with lipofectamine 2000 at a concentration of 100 nM
for 24 h, expression of Qa-1a and Qa-1b in RAW264.7 cells was
tested by RT-PCR (A). The data are expressed as the fold change
in mRNA expression normalized to untreated cells. * p,0.01
compared to the si-control treatment group. NK cells were isolated
after exposed to poly I:C-treated or untreated macrophages and
the expression of NKG2A were determined by flow cytometry.
Data are expressed as the percentage of positively-stained cells (B).
Freshly purified splenic NK cells were first co-cultured with
untreated or poly I:C-pretreated macrophages for 24 h at an NK/
macrophage ratio of 5:1, isolated and were then transfected with
si-NKG2A or si-control, expression of NKG2A in NK cells was
tested by RT-PCR (C), the cytolytic activity of NK cell-mediated
lysis was assessed by the
51Cr release assay (D). Data are expressed
as the mean 6 SD from at least three separate experiments. *
p,0.01 compared to the si-control or isotype control group using
the paired Student’s test.
(TIF)
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